Drug Shortage Report for PROGESTERONE INJECTION, USP
| Report ID | 264718 |
| Drug Identification Number | 02531828 |
| Brand name | PROGESTERONE INJECTION, USP |
| Common or Proper name | PROGESTERONE INJECTION, USP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGESTERONE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 10mL |
| ATC code | G03DA |
| ATC description | PROGESTOGENS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-08-18 |
| Actual start date | |
| Estimated end date | 2026-01-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 STANDISH COURT, SUITE 1050 MISSISSAUGA, ONTARIO CANADA L5R 0G3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-10-20 | French | Compare |
| v6 | 2025-10-20 | English | Compare |
| v5 | 2025-09-30 | French | Compare |
| v4 | 2025-09-30 | English | Compare |
| v3 | 2025-08-19 | English | Compare |
| v2 | 2025-08-08 | French | Compare |
| v1 | 2025-08-08 | English | Compare |
Showing 1 to 7 of 7